Anti-GBM antibody in a patient with diabetic nephropathy; all that glitters is not gold

Hellmark T, Segelmark M (2014) Diagnosis and classification of Goodpasture’s disease (anti-GBM). J Autoimmun 48–49:108–112

Article  PubMed  Google Scholar 

Kuhnl A, Hartwig L, Dahnrich C, Schlumberger W (2022) Serodiagnosis of anti-glomerular basement membrane disease using a newly developed chemiluminescence immunoassay. Front Med (Lausanne) 9:915754

Article  PubMed  Google Scholar 

Segelmark M, Hellmark T (2019) Anti-glomerular basement membrane disease: an update on subgroups, pathogenesis and therapies. Nephrol Dial Transplant 34:1826–1832

Article  CAS  PubMed  Google Scholar 

Mcadoo SP, Pusey CD (2017) Anti-glomerular basement membrane disease. Clin J Am Soc Nephrol 12:1162–1172

Article  CAS  PubMed  PubMed Central  Google Scholar 

Marshall CB (2016) Rethinking glomerular basement membrane thickening in diabetic nephropathy: adaptive or pathogenic? Am J Physiol Renal Physiol 311:F831–F843

Article  CAS  PubMed  Google Scholar 

Borza DB, Bondar O, Colon S, Todd P, Sado Y, Neilson EG, Hudson BG (2005) Goodpasture autoantibodies unmask cryptic epitopes by selectively dissociating autoantigen complexes lacking structural reinforcement: novel mechanisms for immune privilege and autoimmune pathogenesis. J Biol Chem 280:27147–27154

Article  CAS  PubMed  Google Scholar 

Pedchenko V, Bondar O, Fogo AB, Vanacore R, Voziyan P, Kitching AR, Wieslander J, Kashtan C, Borza DB, Neilson EG, Wilson CB, Hudson BG (2010) Molecular architecture of the Goodpasture autoantigen in anti-GBM nephritis. N Engl J Med 363:343–354

Article  CAS  PubMed  PubMed Central  Google Scholar 

McCall AS, Bhave G, Pedchenko V, Hess J, Free M, Little DJ, Baker TP, Pendergraft WF 3rd, Falk RJ, Olson SW, Hudson BG (2018) Inhibitory anti-peroxidasin antibodies in pulmonary-Renal syndromes. J Am Soc Nephrol 29(11):2619–2625

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bhave G, Cummings CF, Vanacore RM, Kumagai-Cresse C et al (2012) Peroxidasin forms sulfilimine chemical bonds using hypohalous acids in tissue genesis. Nat Chem Biol 8:784–790

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ohlsson S, Herlitz H, Lundberg S, Selga D, Molne J, Wieslander J, Segelmark M (2014) Circulating anti-glomerular basement membrane antibodies with predominance of subclass IgG4 and false-negative immunoassay test results in anti-glomerular basement membrane disease. Am J Kidney Dis 63:289–293

Article  PubMed  Google Scholar 

Jia XY, Hu SY, Chen JL, Qu Z, Liu G, Cui Z, Zhao MH (2014) The clinical and immunological features of patients with combined anti-glomerular basement membrane disease and membranous nephropathy. Kidney Int 85:945–952

Article  CAS  PubMed  Google Scholar 

Rutgers A, Slot M, Van Paassen P, Van Breda VP, Heeringa P, Tervaert JW (2005) Coexistence of anti-glomerular basement membrane antibodies and myeloperoxidase-ANCAs in crescentic glomerulonephritis. Am J Kidney Dis 46:253–262

Article  PubMed  Google Scholar 

Sogbein O, Kochar T, Afrouzian M (2023) Epitope spreading: the underlying mechanism for combined membranous lupus nephritis and anti-GBM disease? Case Rep Nephrol 2023:3190042

PubMed  PubMed Central  Google Scholar 

Cui Z, Wang HY, Zhao MH (2006) Natural autoantibodies against glomerular basement membrane exist in normal human sera. Kidney Int 69:894–899

Article  CAS  PubMed  Google Scholar 

Yang R, Cui Z, Hellmark T, Segelmark M, Zhao MH, Wang HY (2007) Natural anti-GBM antibodies from normal human sera recognize alpha3(IV)NC1 restrictively and recognize the same epitopes as anti-GBM antibodies from patients with anti-GBM disease. Clin Immunol 124:207–212

Article  PubMed  Google Scholar 

Zijlstra HW, Mulder AHL, Geeraedts F, Visser F (2018) Falsely positive anti-glomerular basement membrane antibodies in a patient with hantavirus induced acute kidney injury - a case report. BMC Nephrol 19:286

Article  CAS  PubMed  PubMed Central  Google Scholar 

Savige JA, Chang L, Horn S, Crowe SM (1994) Anti-nuclear, anti-neutrophil cytoplasmic and anti-glomerular basement membrane antibodies in HIV-infected individuals. Autoimmunity 18:205–211

Article  CAS  PubMed  Google Scholar 

Prendecki M, Clarke C, Cairns T, Cook T, Roufosse C, Thomas D, Willicombe M, Pusey CD, Mcadoo SP (2020) Anti-glomerular basement membrane disease during the COVID-19 pandemic. Kidney Int 98:780–781

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sinico RA, Radice A, Corace C, Sabadini E, Bollini B (2006) Anti-glomerular basement membrane antibodies in the diagnosis of Goodpasture syndrome: a comparison of different assays. Nephrol Dial Transplant 21(2):397–401

Article  CAS  PubMed  Google Scholar 

Fischer EG, Lager DJ (2006) Anti-glomerular basement membrane glomerulonephritis: a morphologic study of 80 cases. Am J Clin Pathol 125:445–450

Article  PubMed  Google Scholar 

Johansson C, Butkowski R, Swedenborg P, Alm P, Wieslander J (1993) Characterization of a non-Goodpasture autoantibody to type IV collagen. Nephrol Dial Transplant 8:1205–1210

CAS  PubMed  Google Scholar 

Tan SJ, Ducharlet K, Dwyer KM, Myers D, Langham RG, Hill PA (2013) A case of triple pathology: seronegative anti-glomerular basement membrane antibody-mediated glomerulonephritis and membranous nephropathy in a patient with underlying diabetic kidney disease. Clin Kidney J 6:322–326

Article  PubMed  PubMed Central  Google Scholar 

Ahuja TS, Velasco A, Deiss W Jr, Indrikovs AJ, Rajaraman S (1998) Diabetic nephropathy with anti-GBM nephritis. Am J Kidney Dis 31:127–130

Article  CAS  PubMed  Google Scholar 

Curioni S, Ferrario F, Rastaldi MP, Colleoni N, Colasanti G, D’amico G (2002) Anti-GBM nephritis complicating diabetic nephropathy. J Nephrol 15:83–87

PubMed  Google Scholar 

Aoki Y, Tanimoto I, Miyauchi Y, Suzuki Y, Shiojiri T (2017) A case of anti-glomerular basement membrane glomerulonephritis complicated by Type 1 diabetes mellitus, mimicking urinary tract infection. Am J Case Rep 18:308–312

Article  PubMed  PubMed Central  Google Scholar 

Alsaad KO, Herzenberg AM (2007) Distinguishing diabetic nephropathy from other causes of glomerulosclerosis: an update. J Clin Pathol 60:18–26

Article  CAS  PubMed  PubMed Central  Google Scholar 

Williams AJ, Curnock R, Reed CR, Easton P, Rokni S, Bingley PJ (2010) Anti-BSA antibodies are a major cause of non-specific binding in insulin autoantibody radiobinding assays. J Immunol Methods. 362(1–2):199–203

Article  CAS  PubMed  Google Scholar 

Waritani T, Chang J, McKinney B, Terato K (2017) An ELISA protocol to improve the accuracy and reliability of serological antibody assays. MethodsX 30(4):153–165

Article  Google Scholar 

Caza TN, Larsen CP (2023) False-positive anti-PLA2R ELISA testing in patients with diabetes mellitus. Kidney Int. 103(2):425

Article  CAS  PubMed  Google Scholar 

Hoxha E, Reinhard L, Castedello T, Becker JU (2023) False positivity for PLA2R1 antibody measured by ELISA in a nephrotic patient with no membranous nephropathy. Kidney Int 103(2):411–415

Article  CAS  PubMed  Google Scholar 

Olson SW, Arbogast CB, Baker TP, Owshalimpur D, Oliver DK, Abbott KC, Yuan CM (2011) Asymptomatic autoantibodies associate with future anti-glomerular basement membrane disease. J Am Soc Nephrol 22(10):1946–1952

Article  CAS  PubMed  PubMed Central  Google Scholar 

留言 (0)

沒有登入
gif